Clinical Trials Browser

Phase 2 × Neurofibrosarcoma × Everolimus × Clear all

NCT01661283 2019-03-06

SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors

Phase 2 Completed

25 enrolled 15 charts

Sarcoma, Neurofibrosarcoma